Both in Pharmaceuticals
Xeris Biopharma Holdings vs Agios Pharmaceuticals
Over the past year XERS returned +11.7% and AGIO returned −11.3%; their daily moves had a correlation of 0.09.
XERS +11.7% AGIO −11.3%Growth of $1, one year, split-adjusted
| Metric | XERS | AGIO |
|---|---|---|
| Price | $10.75 | $37.23 |
| Market cap | $1.96B | $2.22B |
| Today | +1.03% | −2.33% |
| 1 month | +12.4% | +12.0% |
| 6 months | +75.5% | +33.0% |
| Year to date | +36.9% | +36.8% |
| 1 year | +16.5% | −14.3% |
| Revenue growth (YoY) | +28.7% | +259.3% |
| Gross margin | 86.4% | 93.3% |
| Net margin | −33.8% | −225.1% |
| P/E (TTM) | — | — |
| Price / sales | 5.8× | 22.6× |
| Net cash | -$130.8M | $617.6M |
| Dividend yield | — | — |
| Volatility (60d) | 56.9% | 40.4% |
| Short % of float | 4.6% | 12.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).